z-logo
Premium
Recent progress on the diagnosis of 2019 Novel Coronavirus
Author(s) -
Li Chun,
Ren Linzhu
Publication year - 2020
Publication title -
transboundary and emerging diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.392
H-Index - 63
eISSN - 1865-1682
pISSN - 1865-1674
DOI - 10.1111/tbed.13620
Subject(s) - covid-19 , pandemic , coronavirus , virology , nucleic acid detection , betacoronavirus , medicine , intensive care medicine , disease , computational biology , nucleic acid , biology , infectious disease (medical specialty) , pathology , outbreak , biochemistry
Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a global pandemic. Therefore, convenient, timely and accurate detection of SARS‐CoV‐2 is urgently needed. Here, we review the types, characteristics and shortcomings of various detection methods, as well as perspectives for the SARS‐CoV‐2 diagnosis. Clinically, nucleic acid‐based methods are sensitive but prone to false‐positive. The antibody‐based method has slightly lower sensitivity but higher accuracy. Therefore, it is suggested to combine the two methods to improve the detection accuracy of COVID‐19.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here